Partnering & Licensing.
DNX Biopharmaceuticals is developing long-acting biotherapeutic products for several life-long diseases using novel,
21st century stealth-based, half-life extension and drug delivery technologies that are appropriately matched and integrated to the desired treatment
indication(s).
Please visit our Product Portfolio for more information on the product categories.
For further information on partnering and licensing opportunities, please use the form below to contact us.